GROWTH
Top line decelerating.
+13.6% YoY versus +28.5% prior. 3y CAGR +30.8%.
+13.6%
Inspire Medical Systems, Inc. INSP
Healthcare · Market Cap: $1.2B
Live price unavailable
Fundamentals as of 2026-03-31
We use cookies
MainRatios uses cookies for essential site functions. With your consent, we also use analytics cookies including session replay sampling (PostHog, Google Analytics) and advertising cookies (Google AdSense). You can reject non-essential cookies, including the "sale" or sharing of personal information under CCPA, and you may withdraw consent at any time (GDPR). See our Privacy Policy for details.
Healthcare · Market Cap: $1.2B
Live price unavailable
Fundamentals as of 2026-03-31
All analysis on this page is for educational purposes only and does not constitute financial advice. Fair values are model-based estimates. Always do your own research.
The Question
Bottom line: INSP currently has no legendary investor models qualifying — see /stock/INSP/valuation for the per-model breakdown, but earns a C sector grade (59/100) in Healthcare. Use the per-tab analysis to form your own view. Drill into the valuation breakdown and sector ranking for the full picture.
Yes — Inspire Medical Systems, Inc.'s 16.6% ROE ranks above the S&P 500 median, and D/E 0.15 stays within healthy bounds.
Financial story
Yes — Inspire Medical Systems, Inc.'s 16.6% ROE shows strong capital efficiency, and its 0.15 debt-to-equity stays within healthy bounds.
+13.6% YoY versus +28.5% prior. 3y CAGR +30.8%.
+13.6%Net margin 15.9% versus 6.7% prior (+9.3pp). Operating 5.6%.
15.9%P/E 9.2x — 83% below the 5y median of 54.2x. Forward 45.5x signals EPS contraction next year.
9.2xHow does INSP compare?
INSP's P/E ratio is 9.9x. 5-year P/E history is in the financials tab.
Investor verdicts vary by methodology. Full breakdown by investor and signal is in the valuation tab.
INSP's earnings calendar and history are tracked in the financials tab. Specific dates depend on company-published guidance.
INSP is in the Healthcare sector. Sector ranking and peer comparison are in the sector tab.
0 of 6 legendary investor models rate INSP a BUY. Fair value estimates and full investor breakdown are in the valuation tab.
Inspire Medical Systems, Inc.'s fair value depends on which model you trust. See the per-investor fair-value table in the valuation tab.
See exactly where INSP ranks
Sign in to unlock the full sector ranking — free.
Sign in to see the rankingINSP sits at #19 in Healthcare with a C grade (59/100).
